| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/20/2001 | WO2001068816A1 Human histamine h3 gene variant-3 |
| 09/20/2001 | WO2001068812A2 Methods of stimulating cartilage formation |
| 09/20/2001 | WO2001068805A2 Human olfactory receptors and genes encoding same |
| 09/20/2001 | WO2001068802A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/20/2001 | WO2001068707A1 Human hepatocyte growth factor activator inhibitor homologue |
| 09/20/2001 | WO2001068706A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068704A2 G-protein coupled receptors |
| 09/20/2001 | WO2001068703A1 Human histamine h3 gene variant-2 |
| 09/20/2001 | WO2001068702A2 Regulation of human g protein-coupled receptor |
| 09/20/2001 | WO2001068701A2 Regulation of human seven transmembrane - like g protein - coupled receptor (7tm-gpcr) |
| 09/20/2001 | WO2001068700A2 Regulation of human substance p-like g protein-coupled receptor |
| 09/20/2001 | WO2001068699A2 Regulation of human neuropeptide y-like g protein-coupled receptor |
| 09/20/2001 | WO2001068698A2 Non-selective cation channel |
| 09/20/2001 | WO2001068696A1 Human immune response proteins |
| 09/20/2001 | WO2001068695A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 09/20/2001 | WO2001068693A1 A novel polypeptide, human cannabinoid receptor protein 7 and the polynucleotide encoding thereof |
| 09/20/2001 | WO2001068692A1 A novel polypeptide - human retinoblastoma-binding protein 9 and a polynucleotide sequence encoding the same |
| 09/20/2001 | WO2001068691A1 A novel polypeptide, human fd11 and the polynucleotide encoding there of |
| 09/20/2001 | WO2001068690A1 A new polypeptide-human zinc finger protein 15 and the polynucleotide encoding it |
| 09/20/2001 | WO2001068689A1 A novel polypeptide, human hypoxia-inducible factor 1 alpha subunit 13 and the polynucleotide encoding thereof |
| 09/20/2001 | WO2001068687A1 A novel polypeptide-clathrin light chain 21 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068685A1 A novel polypeptide-human sperm specific protein em1,em6-48 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068684A1 A novel polypeptide-human protocadherins 14 and the polynucleotide encoding said polypeptide |
| 09/20/2001 | WO2001068683A2 Peptide fragments of the equine arteritis virus m protein and their use in diagnostic tests |
| 09/20/2001 | WO2001068682A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | WO2001068681A2 Altered ion channel proteins |
| 09/20/2001 | WO2001068677A2 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 09/20/2001 | WO2001068673A1 Oligonucleotide analogues, methods of synthesis and methods of use |
| 09/20/2001 | WO2001068670A2 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 09/20/2001 | WO2001068668A1 Atm mutations in breast cancer |
| 09/20/2001 | WO2001068665A1 Human histamine h3 gene variant-1 |
| 09/20/2001 | WO2001068130A1 Method and composition for treating airway hyperresponsiveness |
| 09/20/2001 | WO2001068120A2 Uses of bombesin receptor 3 |
| 09/20/2001 | WO2001068109A1 Modified factor viii |
| 09/20/2001 | WO2001067855A2 Transgenic mice containing targeted gene disruptions |
| 09/20/2001 | WO2001067854A1 Chimeric animal model susceptible to human hepatitis c virus infection |
| 09/20/2001 | WO2001034791A3 Chemoreceptors in plant parasitic nematodes |
| 09/20/2001 | WO2001031033A3 Protease from lucila sericata and its use in treatment of wounds |
| 09/20/2001 | WO2001030973A3 Genetic sequences associated with neural cell proliferation and disease |
| 09/20/2001 | WO2001030851A3 Idiotype vaccines |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001025272A3 Compositions and methods for therapy and diagnosis of prostate cancer |
| 09/20/2001 | WO2001019851A3 Opaminergic neuronal survival-promoting factors and uses thereof |
| 09/20/2001 | WO2001019850A3 Nrage nucleic acids and polypeptides and uses thereof |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001016603A3 Analysis and treatment of body weight and eating disorders |
| 09/20/2001 | WO2001016317A3 Polycyclic aromatic hydrocarbon induced molecules |
| 09/20/2001 | WO2001016167A3 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 09/20/2001 | WO2001016165A3 Apoptin-associating protein |
| 09/20/2001 | WO2001014538A3 Plants with modified polyunsaturated fatty acids |
| 09/20/2001 | WO2001014407A3 Refolding of membrane proteins, using two different detergents |
| 09/20/2001 | WO2001013944A3 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 09/20/2001 | WO2001013715A3 Animal model and uses thereof |
| 09/20/2001 | WO2001012661A3 RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS |
| 09/20/2001 | WO2001012660A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 09/20/2001 | WO2001010456A3 Peptides that block viral infectivity and methods of use thereof |
| 09/20/2001 | WO2001008702A9 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 09/20/2001 | WO2001005971A3 Secreted polypeptides and corresponding polynucleotides |
| 09/20/2001 | WO2000075335A3 Bacteriophage rm 378 of a thermophilic host organism |
| 09/20/2001 | WO2000075298A3 Molecules for disease detection and treatment |
| 09/20/2001 | WO2000046246A8 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 09/20/2001 | WO2000045771A9 Suppression of transformation of cells by the transcription factor egr |
| 09/20/2001 | WO2000043028A9 Method of treating chronic cardiac disease |
| 09/20/2001 | WO2000040204A9 Methods for treating cystic fibrosis |
| 09/20/2001 | WO2000037491A3 Dnas encoding proteins with signal sequences |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/20/2001 | WO2000034436A3 Facs assisted methods for introducing individual chromosomes into cells |
| 09/20/2001 | WO1999058556A3 Protein associated to hereditary spastic paraplegia |
| 09/20/2001 | WO1999040102A9 Novel molecules of the card-related protein family and uses thereof |
| 09/20/2001 | US20010023500 Leukotriene B4 receptor transgenic mice |
| 09/20/2001 | US20010023289 Detecting nucleic acids encoding mammalian polypeptides,antisense oligonucleotides.screening agonists or antagonists of receptors |
| 09/20/2001 | US20010023244 Thrombin inhibitors |
| 09/20/2001 | US20010023242 Polypeptide from snake venom |
| 09/20/2001 | US20010023070 Isolated polypeptide; genetic engineering |
| 09/20/2001 | US20010023069 Method for making insulin precursors and insulin precursor analogs |
| 09/20/2001 | US20010023066 Methods of screening for or treating cancers or autoimmune disorders in which a complement C3 or C3 related protein is associated |
| 09/20/2001 | US20010023062 Screening receptors |
| 09/20/2001 | US20010022971 IBD-associated microbial nucleic acid molecules |
| 09/20/2001 | DE10013618A1 New polypeptides from Drosophila melanogaster have biological activity of peptide receptor, useful to find new compounds for plant protection and insecticides |
| 09/20/2001 | DE10013580A1 Rezeptor für Latrotoxin aus Insekten Receptor for Latrotoxin from insects |
| 09/20/2001 | DE10013296A1 New nucleic acid encoding the non-selective cation channel OTRPC4, useful for treating osmolality-associated disorders, e.g. diabetes comprises the modulation of activity |
| 09/20/2001 | DE10011358A1 Producing a modified L-form bacterial strain by culturing the strain in complex medium and subjecting it to temperature stress, provides bacteria useful to produce recombinant proteins |
| 09/20/2001 | CA2539214A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534391A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534186A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534030A1 Screted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534018A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533991A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533903A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533831A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2531917A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2406672A1 Atm mutations in breast cancer |
| 09/20/2001 | CA2403405A1 Hcv ns2/3 fragments and uses thereof |
| 09/20/2001 | CA2403201A1 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 09/20/2001 | CA2403196A1 Method and composition for treating airway hyperresponsiveness |
| 09/20/2001 | CA2403189A1 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof |
| 09/20/2001 | CA2403113A1 Methods of improving homologous recombination |
| 09/20/2001 | CA2402940A1 G-protein coupled receptors |
| 09/20/2001 | CA2402912A1 Transgenic mice containing targeted gene disruptions |